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ABSTRACT 
A series of  dichlorides (Ia-h) followed by 1, 3, 4-Thiadiazol-2-Amine (II a-h)  were synthesized by using various 
dicarboxylic acids(a-h), the further reaction of (I) was carried out with thiosemicarbazide in presence of sulphuric acid  to 
converted into corresponding 1, 3, 4-Thiadiazol-2-Amine (II a-h) The structures of these compounds were confirmed by 
IR, NMR and Mass spectral analysis. The newly synthesized compounds were evaluated for the antibacterial and 
antifungal activity. The results show that compound (IIa), (IIe), (IIf) and (IIh) exhibited moderate to good antibacterial 
and antifungal activity at 5-100 mcg/ml. 
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INTRODUCTION 
Antimicrobials are one of a very important category of drug; 
these classes of drugs are prescribed right from a simple 
infection to the serious diseases like cancer and also in life 
threatening infections like meningitis. So it is quite clear 
from the spectrum of use that these categories of drugs are 
very important from medical point of view. But microbial 
resistance towards the drug creates a very serious problem; 
because of this development of resistance many drugs are 
now useless which were very effective before. Moreover, the 
toxic effects produced by these antibiotics are also reducing 
their significance. So the need for new antimicrobial is 
always be their.  
It is known that many 1, 3, 4-thiadiazole and 1, 2, 4-triazole 
derivatives have biological activity, with their antibacterial 
[1-
3], antimycobacterial 
[4-5], antimycotic 
[6], antifungal 
[7-8], 
antidepressive 
[9], and cardiotonic 
[10] action being notable. 
Recent research has also established for these heterocycles an 
analgesic 
[11]  and anti-inflammatory 
[12-13] activities. 
Meanwhile, N-acylated amino acids are known for their 
hepatoprotective 
[14], antimicrobial 
[15-16] and antitumor 
action. 
[17-18]   
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Taking these data into account, in the present study, we 
describe herein the synthesis of some triazole, thiadiazole 
derivatives and evaluation of their antimicrobial activities. 
The present work comprises of synthesis of new 
antimicrobial agent, in which dicarboxylic acids are used as a 
starting material, to which the heterocyclic rings i.e. 
thiadiazole and triazole are substituted (it is reported that the 
presence of heterocyclic ring in lead structure increases the 
probability of that compound to be a good antimicrobial) so 
due to the presence of above features in new compounds we 
can say that the drug should exhibit good antimicrobial 
activity.  
 
MATERIAL AND METHOD 
Chemistry  
The synthesis of dichloride (Ia-h) (I) was carried out by the 
reaction of various dicarboxylic acids and thionyl chloride; it 
is well established. 
[23] The various substituted 1, 3, 4-
Thiadiazol-2-Amine (II a-h) were prepared by reacting with 
thiosemicarbazide (2 mol) in sulphuric acid derivatives as 
shown in Scheme I. The reaction and purity of compounds 
were monitored by TLC using precoated silica gel. Structures 
of the compounds were confirmed by spectral studies. 
Biological Activity 
The synthesized compounds were screened for the 
antibacterial and antifungal activity by using the agar-cup Barve et al. / Synthesis, Characterization and Antimicrobial Activity………………. 
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technique in nutrients agar and potato dextrose agar media 
respectively 
[19-30] Ciprofloxacin and Gresiofluvin were used 
as standard drug for the antibacterial and antifungal activity 
respectively and zone of inhibition of all newly synthesized 
compounds (IIIa-j) and (IVa-j) was measured against these 
standard drug (Table I and II). The novel synthesized 
compounds have shown moderate activity against bacterial 
strain compared to standard drug. The title compounds have 
showed the better antibacterial activity and antifungal 
activity compared with the standard drug. Microbial strains- 
Staphylococcus aureus NCIM 2602; Bacillus subtilis NCIM 
2613; Escherichia coil NCIM 2666; Pseudomonas 
aeruginosa NCIM 5225; Saccharomyces cerevisiae NCIM 
3220;  Candida albicans  NCIM 3471; Aspergillus niger 
NCIM 813. 
Experimental Section 
Melting points were determined in Thermonik melting point 
apparatus and are uncorrected. IR spectrum was recorded on 
Thermonicolet FTIR 200 spectrophotometer by using KBr 
pellet values are expressed in cm
-1. NMR spectra were 
recorded in DMSO-d6 using varian 300Mz mercury plus and 
chemical shift are reported in δ (ppm). Mass spectra were 
recorded on GCMS-QP 2010 Shimaduzu and mass values are 
reported in m/z.  
Microbial strains- Staphylococcus aureus  NCIM 2602; 
Bacillus subtillis NCIM 2613; Escherichia coil NCIM 2666; 
Pseudomonas Aeruginosa NCIM  5225;  Aspergillus niger 
NCIM 813;  Saccharomyces cerevisiae  NCIM 3220; 
Candida albicans NCIM 3471. All the chemicals used are of 
reagent grade and substituted aromatic amines and other 
chemicals used during synthesis are of SD fine grade.  
 
 
Method of Synthesis for Thiadiazole Derivatives 
STEP-1 
Synthesis of Acid Chloride 
[31] (I a-h) 
Dicarboxylic acid (1mol) and thionyl chloride (2 mol) were 
taken in round bottom flask and this reaction mixture was 
heated in water bath with occasional stirring for 20-30 min 
till no more hydrogen chloride evolved. Subsequently the 
solution was refluxed for two hrs, and distilled off. The acid 
chloride thus obtained, was used as such for further reaction 
without any purification. 
Conversion of a carboxylic acid to an acid chloride cannot be 
done with aqueous HCl (the more stable acid is favored), but 
must be done with anhydrous SOCl2 or PCl3. 
STEP-2 
Synthesis of 1, 3, 4-Thiadiazol-2-Amine 
[32] (II a-h) 
A mixture of acid chloride (1 mol) and thiosemicarbazide (2 
mol) in sulphuric acid 10 ml were heated on a boiling water 
bath for 5hrs. Ethanol was added to the mixture, and heated 
under reflux for 10 h. The reaction mixture was cooled to 
room temperature and poured into ice cold water. The 
precipitated solid was filtered, washed with water and dried 
product was recrystallised from suitable solvents. 
[15]  
1.  5-((5′-amino-1′, 3′, 4′-thiadiazol-2′-yl) methyl)-1, 3, 
4-thiadiazol-2-amine (Ia). 
M.P. (ºC): 120-122, % Yield: 68.4, IR-(KBr): (C-S Het 
str.)711, (C-N Het str.) 1461, (N-N str.) 1625, 
(Aliphatic C-H str.) 2888, (N-H str.) 3484 cm
-1
.
1H 
N.M.R (DMSO): 3.596 (s, 2H, CH), 3.954 (s, 4H, NH) 
2.  5-(2″-(5′-amino-1′, 3′, 4′-thiadiazol-2′-yl) ethyl)-1, 3, 
4-thiadiazol-2-amine (Ib). 
M.P. (ºC): 132-134, % Yield: 64.6. IR-(KBr): (C-S Het 
str.) 646, (C-N Het str.) 1531, (N-N str. 1620), 
(Aliphatic C-H str.) 2962, (N-H str.) 3473 cm
-1
.
1H 
N.M.R (DMSO) - 3.045 (s, 4H, CH), 3.563 (s, 4H, NH) 
3.  5-(3″-(5′-amino-1′, 3′, 4′-thiadiazol-2′yl) propyl)-1, 3, 
4-thiadiazol-2-amine (Ic).  
M.P. (ºC): 106-108, % Yield: 69.1, IR-(KBr): (C-S Het 
str.) 671, (C-N Het str.) 1560, (N-N str.)1606, 
(Aliphatic C-H str.) 2893, (N-H str.) 3460 cm
-1.
 1 H 
N.M.R (DMSO): 1.78-1.86 (p, 2H, CH, J=8), 2.71-2.74. 
(t, 4H, CH, J=7.2), 3.817 (s, 4H, NH)  
4.  5-(4″-(5′-amino-1′, 3′, 4′-thiadiazol-2′yl) butyl)-1, 3, 
4-thiadiazol-2-amine (Id). 
M.P. (ºC): 104-106, % Yield: 61.5. IR-(KBr): (C-S Het 
str.) 688,(C-N Het str.) 1452, (N-N str.) 1581,(Aliphatic 
C-H str.) 2954, (N-H str.) 3454 cm
-1  .
1H N.M.R 
(DMSO): 1.4-1.7(m, 4H, CH), 2.3-2.8 (m, 4H, CH), 
3.726 (s, 4H, CH)  
5.  5-(5″-(5′-amino-1′, 3′, 4′-thiadiazol-2′yl) pentyl)-1, 3, 
4-thiadiazol-2-amine (Ie).  
M.P. (ºC): 136-138, % Yield: 63.5. IR-(KBr): (C-S Het 
str.) 686, (C-N Het str.) 1483, (N-N str.) 1598, 
(Aliphatic C-H str.) 2887, (N-H str.) 3467 cm
-1  .
1H 
N.M.R (DMSO): 1.15-1.21 (p, 2H, CH, J-6), 1.53-1.61 
(p, 4H, CH, J=8), 2.50-2.53(t, 4H, CH, J=7.2), 3.734 (s, 
4H, NH) 
6.  5-(6″-(5′-amino-1′, 3′, 4′-thiadiazol-2′yl) hexyl)-1, 3, 
4-thiadiazol-2-amine (If).  
M.P. (ºC): 128-130, % Yield: 66.7. IR-(KBr): (C-S Het 
str.) 694, (C-N Het str.) 1485, (N-N str.) 1637, 
(Aliphatic C-H str.) 2873, (N-H str.) 3510 cm
-1.
1H 
N.M.R (DMSO): 1.19-1.33(m, 4H, CH), 1.34-1.81 (m, 
4H, CH), 1.42-1.47 (t, 4H, CH, J=8.8), 3.788(s, 4H, 
NH)  
7.  5-(7″-(5′-amino-1′, 3′, 4′-thiadiazol-2′yl) heptyl)-1, 3, 
4-thiadiazol-2-amine (Ig).  
M.P. (ºC): > 300, % Yield: 69.6. IR-(KBr): (C-S Het 
str.) 682, (C-N Het str.) 1465,   (N-N str.) 1571, Barve et al. / Synthesis, Characterization and Antimicrobial Activity………………. 
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(Aliphatic C-H str.) 2850, (N-H str.) 3452 cm
-1.
1H 
N.M.R (DMSO): 1.1-1.4 (m, 6H, CH), 1.6-1.9 (m, 4H, 
CH), 2.51-2.54 (t, 4H, CH, J=6.4), 4.034 (s, 4H, NH) 
8.  5-(8″-(5′-amino-1′, 3′, 4′-thiadiazol-2′yl) octyl)-1, 3, 
4-thiadiazol-2-amine (Ih).  
M.P. (ºC): 144-146, % Yield: 65.8. IR-(KBr): (C-S Het 
str.) 690, (C-N Het str.) 1452, (N-N str.) 1579, 
(Aliphatic C-H str.) 2864, (N-H str.) 3461 cm
-1.
1H 
N.M.R (DMSO) - 1.14-1.39 (m, 8H, CH), 1.51-1.92(m, 
4H, CH), 2.43-2.49(t, 4H, CH, J=12), 3.873 (s, 4H, NH)  
 
RESULT AND DISCUSSION 
We have synthesized a series of eight novel 1, 3, 4-
Thiadiazol-2-Amine (IIa-h) derivatives using dichlorides of 
various dicarboxylic acids. Structures of the synthesized 
compounds were established on the basis of IR, 
1H NMR, 
Mass and HRMS spectral data in order to substantiate the 
structures of the compounds.  
Compounds (IIa-h) showed absorption bands ranging from 
670-715 cm
-1 for C-S Hetero str. and 3460-3510 cm
-1 for N-
H str. 1575-1630 cm
-1 for N-N str. 1430-1600 cm
-1 for C-N 
Hetero str., 2840-3000 cm
-1 for Aliphatic C-H str., 1575-
1630 cm
-1 for N-N str., but not showed any bands ranging 
1700-1725 for C=O str., 3500-3560 for O-H str., and 1345-
1400 for C-O str., which ensures the absence of any acidic 
group in synthesized compounds. These data gave 
conformation of formation of thiadiazole ring in their 
respective spectra. 
In particular, it must be pointed out that in 
1H NMR the 
characteristic peaks at δ 3.296 ppm (CH3 group of aliphatic 
chain),  δ 3.957 ppm (N-H group of amine attached with 
thiadiazole), indicate the presence of above groups in their 
respective structure. The compounds (II a-j) showed 
prominent singlet at δ 1.19-1.33, m, 4H. and 1.34-1.81, m, 
4H. for subsequent protons of CH3 groups present in aliphatic 
chain between two thiadiazole rings. 
 
 
In 
13CNMR the characteristic peaks appeared at 159-162 ppm 
showed the peaks of aromatic carbon in molecule, peaks at 
31.20 conforms the methyl group on aliphatic chain ring, 
these information conforms the formation of desired 
compound.  
Gram-positive bacterial strains: B. subtillis -Bacillus 
Subtillis; S. aureus- Staphylococcus aureus Gram-negative 
bacterial strains: E coli –Escherichia coli;  P.aeruginosa– 
Pseudomonas Fungal strains: S. cerevisiae -; C. Albicans -
Candida Albicans; A. niger- Aspergillus niger. 
The synthesized compounds were evaluated for in vitro 
antibacterial and antifungal activity against various strains 
Gram-positive bacterial strains: Bacillus Subtillis; 
Staphylococcus aureus, Gram-negative bacterial strains: 
Escherichia coli;  Pseudomonas aeruginosa, Fungal strains 
Saccharomyces cerevisiae; Aspergillus niger, Candida 
albicans using nutrient agar cup plate method. The results are 
given in Table-I. 
We studied the effect of thiadiazole amine ring. The results 
showed that compounds (IIa), (IIe), (IIf) and (IIh) exhibited 
comparable antibacterial and antifungal activity with the 
standard antibiotics ciprofloxin and greseofluvin. It has been 
observed that compound (IIa) show better antibacterial and 
antifungal activity compare to others compounds (IIe), (IIe) 
and  (IIh) were shown satisfactory antibacterial and 
antifungal activity. 
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